Viela Bio (VIE) Tops Q3 EPS by 7c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Viela Bio (VIE) Tops Q3 EPS by 7c, Revenues Miss

Viela Bio Reports Third Quarter 2020 Financial Results and Program Highlights

November 10, 2020 4:15 PM EST

GAITHERSBURG, Md., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq: VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today reported financial results and provided program highlights for the third quarter ended September 30, 2020.

Several months into UPLIZNAs launch, we have gained valuable insights into how to meet our customers needs, which continue to evolve during the COVID-19 pandemic. We are encouraged by the increasing product uptake and our commercial team remains nimble in how we engage with individual practitioners and centers of... More